(1)
Ciapponi, A.; Bardach, A.; Colaci, C.; Rodríguez Cairoli, F.; Argento, F.; Korbenfeld, E.; García Martí, S. Trastuzumab-Emtansine Versus Other Anti-HER2 Regimens in Early or Unresectable or Metastatic HER2 Positive Breast Cancer: Systematic Review and Network Meta-Analysis. Rev Peru Med Exp Salud Publica 2024, 41 (1), 7-18. https://doi.org/10.17843/rpmesp.2024.411.13351.